Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Sutro Biopharma, Inc. (STRO), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
-0.62
P/B ratioShare price divided by book value per share.
-1.73
P/S ratioMarket value divided by annual revenue.
3.91
PEG ratioP/E divided by the earnings growth rate.
-0.02
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
-1.01
EV / RevenueEnterprise value against annual revenue.
2.96
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
-119.05%
Free cash flow yieldFree cash flow as a percentage of market value.
-81.39%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
97.20%
Operating marginRevenue left after operating costs.
-309.87%
Net marginRevenue left after every cost, including tax and interest.
-395.25%
Return on equityProfit as a percentage of shareholders’ equity.
185.30%
Return on assetsProfit as a percentage of total assets.
-92.89%
Return on capital employedOperating profit against the capital the business uses.
-100.04%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
3.32
Quick ratioThe same, excluding inventory.
3.32
Cash ratioCash alone against current liabilities.
0.77
Debt to equityTotal borrowings against shareholders’ equity.
-0.10
Debt to assetsTotal borrowings against total assets.
0.09
Interest coverageHow many times operating profit covers the interest bill.
-3.53
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$-22.49
Book value per shareShareholders’ equity divided by shares outstanding.
$0.00
Shares outstandingShares currently issued.
0
Market capitalisationShare price times shares outstanding.
$154.70M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$359.91M
EmployeesReported headcount.
269
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Payout ratioShare of profit paid out as dividends.
0.00%
Sutro Biopharma, Inc. (STRO) statistics — frequently asked questions
What is Sutro Biopharma, Inc.'s P/E ratio?
Sutro Biopharma, Inc. (STRO) trades on a price-to-earnings ratio of -0.62. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.
What is Sutro Biopharma, Inc.'s return on equity?
Sutro Biopharma, Inc. (STRO) reports a return on equity of 185.30%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Sutro Biopharma, Inc. carry?
Sutro Biopharma, Inc. (STRO) has a debt-to-equity ratio of -0.10, which compares total borrowings with shareholders' equity.
What is Sutro Biopharma, Inc.'s profit margin?
Sutro Biopharma, Inc. (STRO) keeps -395.25% of revenue as net profit after every cost, including tax and interest.